Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Medicine (Baltimore) ; 97(49): e13424, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30544421

RESUMEN

PURPOSE: Many studies have demonstrated the advantage of maintaining intraoperative deep neuromuscular block (NMB) with sugammadex. This trial is designed to evaluate the impact of muscle relaxation during laparoscopic subtotal gastrectomy on the oncological benefits, particularly in obese patients with gastric cancer. MATERIALS AND METHODS: This is a double-blind, randomized controlled multicenter prospective trial. Patients with clinical stage I-II gastric cancer with a body mass index of 25 and over, who undergo laparoscopic subtotal gastrectomy will be eligible for trial inclusion. The patients will be randomized into a deep NMB group or a moderate NMB group with a 1:1 ratio. A total of 196 patients (98 per group) are required. The primary endpoint is the number of harvested lymph nodes, which is a critical index of the quality of surgery in gastric cancer treatment. The secondary endpoints are surgeon's surgical condition score, patient's sedation score, and surgical outcomes including peak inspiratory pressure, operation time, postoperative pain, and morbidity. DISCUSSION: This is the first study that compares deep NMB with moderate NMB during laparoscopic gastrectomy in obese patients with gastric cancer. We hope to show the oncologic benefits of deep NMB compared with moderate NMB during subtotal gastrectomy. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov (NCT03196791), date of registration: October 10, 2017.


Asunto(s)
Gastrectomía , Laparoscopía , Bloqueo Neuromuscular/métodos , Obesidad/complicaciones , Neoplasias Gástricas/complicaciones , Neoplasias Gástricas/terapia , Adulto , Anciano , Método Doble Ciego , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias , Selección de Paciente , Neoplasias Gástricas/patología , Resultado del Tratamiento , Adulto Joven
2.
Sci Rep ; 6: 32322, 2016 08 31.
Artículo en Inglés | MEDLINE | ID: mdl-27577999

RESUMEN

Triclosan (TCS) is a widely used antimicrobial agent and TCS resistance is considered to have evolved in diverse organisms with extensive use of TCS, but distribution of TCS resistance has not been well characterized. Functional screening of the soil metagenome in this study has revealed that a variety of target enoyl acyl carrier protein reductases (ENR) homologues are responsible for the majority of TCS resistance. Diverse ENRs similar to 7-α-hydroxysteroid dehydrogenase (7-α-HSDH), FabG, or the unusual YX7K-type ENR conferred extreme tolerance to TCS. The TCS-refractory 7-α HSDH-like ENR and the TCS-resistant YX7K-type ENR seem to be prevalent in human pathogenic bacteria, suggesting that a selective enrichment occurred in pathogenic bacteria in soil. Additionally, resistance to multiple antibiotics was found to be mediated by antibiotic resistance genes that co-localize with TCS resistance determinants. Further comparative analysis of ENRs from 13 different environments has revealed a huge diversity of both prototypic and metagenomic TCS-resistant ENRs, in addition to a selective enrichment of TCS-resistant specific ENRs in presumably TCS-contaminated environments with reduced ENR diversity. Our results suggest that long-term extensive use of TCS can lead to the selective emergence of TCS-resistant bacterial pathogens, possibly with additional resistance to multiple antibiotics, in natural environments.


Asunto(s)
Bacterias/efectos de los fármacos , Farmacorresistencia Microbiana/genética , Enoil-ACP Reductasa (NADH)/genética , Metagenoma/genética , Oxidorreductasas de Alcohol/genética , Bacterias/genética , Bacterias/patogenicidad , Farmacorresistencia Microbiana/efectos de los fármacos , Enoil-ACP Reductasa (NADH)/efectos de los fármacos , Humanos , Hidroxiesteroide Deshidrogenasas/genética , Metagenoma/efectos de los fármacos , Pruebas de Sensibilidad Microbiana , Triclosán/uso terapéutico
3.
J Microbiol Biotechnol ; 25(4): 511-20, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25370725

RESUMEN

Triclosan, the widely used biocide, specifically targets enoyl-acyl carrier protein reductase (ENR) in the bacterial fatty acid synthesis system. Although the fish pathogen Aeromonas salmonicida subsp. salmonicida exhibits triclosan resistance, the nature of this resistance has not been elucidated. Here, we aimed to characterize the triclosan resistance of A. salmonicida subsp. salmonicida causing furunculosis. The fosmid library of triclosan-resistant A. salmonicida subsp. salmonicida was constructed to select a fosmid clone showing triclosan resistance. With the fosmid clone showing triclosan resistance, a subsequent secondary library search resulted in the selection of subclone pTSR-1. DNA sequence analysis of pTSR-1 revealed the presence of a chromosomal-borne fabV-encoding ENR homolog. The ENR of A. salmonicida (FabVas) exhibited significant homology with previously known FabV, including the catalytic domain YX(8)K. fabVas introduction into E. coli dramatically increased its resistance to triclosan. Heterologous expression of FabVas might functionally replace the triclosan-sensitive FabI in vivo to confer E. coli with triclosan resistance. A genome-wide search for fabVas homologs revealed the presence of an additional fabV gene (fabVas2) paralog in A. salmonicida strains and the fabVas orthologs from other gram-negative fish pathogens. Both of the potential FabV ENRs expressed similarly with or without triclosan supplement. This is the first report about the presence of two potential FabV ENRs in a single pathogenic bacterium. Our result suggests that triclosan-resistant ENRs are widely distributed in various bacteria in nature, and the wide use of this biocide can spread these triclosan-tolerant ENRs among fish pathogens and other pathogenic bacteria.


Asunto(s)
Aeromonas salmonicida/efectos de los fármacos , Aeromonas salmonicida/enzimología , Antiinfecciosos Locales/farmacología , Farmacorresistencia Bacteriana , Enoil-ACP Reductasa (NADPH Específica B)/metabolismo , Triclosán/farmacología , Aeromonas salmonicida/genética , Secuencia de Aminoácidos , Animales , Clonación Molecular , Farmacorresistencia Bacteriana/genética , Enoil-ACP Reductasa (NADPH Específica B)/química , Enoil-ACP Reductasa (NADPH Específica B)/genética , Peces/microbiología , Regulación Bacteriana de la Expresión Génica , Pruebas de Sensibilidad Microbiana , Datos de Secuencia Molecular , Plásmidos/genética , Dominios y Motivos de Interacción de Proteínas , Alineación de Secuencia , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA